UP-818-CC

· EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UP-818-CC, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: UP-818-CC Injection in Healthy Chinese Subjects [Phase 1]